Kurt Graves

Insider Reports History

Identity 1 identity field
Location
New Haven, CT
SEC source record 1 source field
Owner filing signature
/s/ Thomas J. DesRosier, Attorney-in-Fact
Source evidence 1 source field
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Kurt Graves

Form 4 holding Director

Seres Therapeutics, Inc.

Security class
Stock Option (right to buy)
Shares / value
100,000
Estimated value
Report date
10 Apr 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Kurt Graves

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .